David Lugo Palacios

Assistant Prof in Health Economics @LSHTM_GHECO
BA Econ @ITAM_mx | MSc Health Econ @bse_barcelona | PhD Health Econ @LSHTM
@Chivas de corazón! 🇲🇽

[David Lugo Palacios @dlugopal]

Muchas gracias @iacs_aragon por la invitación a las #JornadasRedETS2024! Gran evento con mesas súper interesantes!! Espero volver pronto a Zaragoza!!

[IACS (Salud-Aragón) @iacs_aragon]

“La innovación digital ha permitido la generación, colección y almacenamiento de un gran volumen de datos relacionados con la salud que nos dan información del paciente”

David Lugo Palacios @dlugopal. Profesor Asistente. The London School of Hygiene and Tropical Medicine

[David Lugo Palacios @dlugopal]

@MattXSutton @LSHTM Sorry! It was too late for it to be changed! 🙈 For what is worth, I think it's a cool pic! 😬

[David Lugo Palacios @dlugopal]

Join us tomorrow for @MattXSutton's seminar!
If you are in London, seminar is @LSHTM's Manson Lecture theatre. All welcome!

[Global Health Economics Centre @LSHTM_GHECO]

Join the next GHECO seminar with Professor Matt Sutton. The session will explore the use of supply-demand interactions to estimate effects of population health interventions.

🗓️ Wednesday 2 October 2024
🕐 13:00 BST
▶️ https://t.co/W5N9vqAA9m

[David Lugo Palacios @dlugopal]

3) Previous target trial emulations have assumed no unobserved confounding. While we found that this is a plausible assumption amongst the RCT-eligible subpopulation, our results suggest that this assumption is likely implausible for the RCT-ineligible subpopulation

[David Lugo Palacios @dlugopal]

New @LSHTM_GHECO + @Basucally + @DrAmandaAdler + @karlado paper on @HECJournalTweet!

We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT

https://t.co/udjoOURUfz

[David Lugo Palacios @dlugopal]

2) We assess the performance of a local #IV approach vs a published RCT and explore essential heterogeneity across an entire target population, including subpopulations who met RCT eligibility criteria and those who did not

[David Lugo Palacios @dlugopal]

@jd_wilko A bit of self-promotion here, but sharing the link to the SAP from our #PERMIT study. Hope it's helpful!
https://t.co/aoW0FttMZy

[David Lugo Palacios @dlugopal]

Our research showing how #IV methods can help inform clinical practice
@pbidulka @CarrollOrlagh @Basucally @DrAmandaAdler @kamleshkhunti @SONeill1999 @RJ_Silverwood @TheStatsGeek @LiamSmeeth1

[The BMJ @bmj_latest]

This research in @bmj_latest compared the effectiveness of three antidiabetic drugs for people with type 2 #diabetes mellitus.

SGLT-2 inhibitors were more effective second line treatments compared with DPP-4 inhibitors or sulfonylureas, @pbidulka
https://t.co/hl5dfHPWxh

[David Lugo Palacios @dlugopal]

New @LSHTM_GHECO paper on @bmj_latest ! We assessed the comparative effectiveness of 3 second line antidiabetics by emulating a target trial with #IVs and electronic health records

https://t.co/GT4AGbXBjF

[David Lugo Palacios @dlugopal]

@HealthEcon_Will Congrats, Will! All the best!!

[David Lugo Palacios @dlugopal]

@raulpacheco @EGobiernoyTP @LSHTM_GHECO Claro! Avísame si te das una vuelta y coordinamos!

[David Lugo Palacios @dlugopal]

Muy agradecido por la invitación de la @EGobiernoyTP para presentar un trabajo con colegas de @LSHTM_GHECO utilizando #targettrials y #LocalIV para estimar efectos de tratamiento heterogéneos

[Escuela de Gobierno @EGobiernoyTP]

Hoy, @dlugopal, de @LSHTM, presentó estudio que muestra cómo los métodos de variable instrumental local (VIL) pueden proporcionar evidencia útil sobre la heterogeneidad del efecto de tratamientos médicos, incluyendo variables no observables.

#FormamosElFuturo

[David Lugo Palacios @dlugopal]

@raulpacheco @EGobiernoyTP @LSHTM_GHECO Sí! Aunque ya estoy por salir de regreso a UK...

[David Lugo Palacios @dlugopal]

@hectorjuanvp @EGobiernoyTP @LSHTM_GHECO Muchas gracias, Héctor! Disfruté mucho la visita, las preguntas y la discusión que tuvimos ayer.

[David Lugo Palacios @dlugopal]

@mr_nunal Gracias, Alberto! Un abrazo!

[David Lugo Palacios @dlugopal]

There are two vacancies in our team for health economists/data scientists/statisticians! Join us!! @LSHTM_GHECO

https://t.co/3E5eAyACqo

https://t.co/58vYHMg2wq

[Global Health Economics Centre @LSHTM_GHECO]

📢 @LSHTM is hiring two Research Fellows in #HealthEconomics/medical statistics/data science.

Join our vibrant team, working with leading health economists, clinicians & statisticians, to advance quants methods & answer major policy questions.

5 Feb ⏰ https://t.co/R06KkI7xjt

[Javier “Chicharito” Hernández @CH14_]

Mi casa, mi familia, mi equipo, mi todo. Nos vemos pronto! @Chivas

[David Lugo Palacios @dlugopal]

He's coming home!! 🐐 #HO14CHICHARITO @Chivas

[Manchester United @ManUtd]

Always classy, Sir Alex 🫶

A heartfelt message for @CH14_ ahead of his return to his hometown club @Chivas 🇲🇽

#MUFC || #HO14CHICHARITO

[David Lugo Palacios @dlugopal]

It's my very big pleasure to share the fantastic news that @lkovacevic1 has successfully passed her PhD viva earlier today! Congrats Dr Kovacevic! Massive thanks to @HealthEcon_Will and Brendan Delaney for examining and facilitating a really interesting discussion!!